Tikun Olam Cannbit reported acquisition of 20% of Gynica. Tikun Olam-Cannbit announced the start of a joint clinical study that is the first of its kind worldwide for a cannabis-based vaginal product to treat gynecological problems for which to date there has been no solution. The study will be led by Prof. Moshe Hod, a renowned international gynecology expert and President of the European Association of Perinatal Medicine (EAPM).